SEC Form 4 · accession 0001615774-18-000386
Ensysce Biosciences, Inc. · ENSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Peng
Officer — Chief Financial Officer
Period of report
Jan 15, 2018
Accepted (ET)
Jan 17, 2018 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 15, 2018 | J | 13,251 | $0.00 | D | 87,014 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As contemplated by the securities subscription agreement between the reporting person and the Company, 13,251 shares held by Mr. Peng were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.